HUNTSVILLE, Ala.--(BUSINESS WIRE)--InQ Biosciences, a provider of innovative technologies for cell growth and research, today announced that a pre-commercial version of its InQ Cell Research System is being utilized in a University of Alabama at Birmingham (UAB) study evaluating the effects of secondary injury components on brain cells. The InQ system integrates a dynamically controlled sample environment with advanced live cell imaging and real-time data collection.
